Century Enka Q1 Results: Net profit surges 52% to ₹100.8 crore
Century Enka posted a 52% YoY increase in Q1FY26 net profit to ₹1,008 crore, driven by margin expansion to 8.67% despite a 14.8% revenue drop. The company raised its dividend to ₹11 per share and reduced borrowings significantly.

*this image is generated using AI for illustrative purposes only.
Century Enka Limited reported a sharp recovery in profitability for the quarter ended March 31, 2026, with net profit after tax (PAT) surging 52% year-on-year to ₹1,008 million. This performance was primarily driven by significant margin expansion, as EBITDA margins widened to 8.67% from 5.73% in the corresponding period of FY25, offsetting a 14.8% decline in operational revenue to ₹17,054 million. The company also declared a dividend of ₹11 per share, an increase from ₹10 per share in FY25.
The financial results were filed pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015. The filing highlights that while revenue contracted due to lower sales volumes (73,693 MT vs 78,425 MT in FY25), cost optimization and improved operational efficiency led to total expenses falling to ₹15,576 million from ₹18,870 million in the previous year. Finance costs also decreased to ₹29 million from ₹45 million.
Financial Performance Highlights
The company’s bottom line strengthened significantly, with PAT margins expanding to 5.91% from 3.32% in Q1FY25. EBITDA rose 28.8% to ₹1,478 million. Other income contributed ₹419 million, up from ₹373 million in the prior year. However, the results included an exceptional item of ₹19 million related to the impact of the new Labour Code.
| Metric | Q1FY26 (₹ Mn) | Q1FY25 (₹ Mn) | YoY Change |
|---|---|---|---|
| Operational Revenue | 17,054 | 20,017 | -14.8% |
| EBITDA | 1,478 | 1,147 | +28.8% |
| EBITDA Margin | 8.67% | 5.73% | +294 bps |
| Net Profit (PAT) | 1,008 | 665 | +51.6% |
| EPS (₹) | 46.15 | 30.42 | +51.7% |
Segmental and Operational Insights
Revenue from the Yarn segment declined to ₹8,280 million from ₹9,582 million in Q1FY25, while the Reinforcement segment saw revenues drop to ₹8,162 million from ₹9,547 million. Despite the volume contraction, the company maintained its market leadership with a 24% domestic market share in Nylon Filament Yarn and 25% in Nylon Tyre Cord Fabric. The product mix remained balanced, with Reinforcement contributing 48% of sales and Yarn 49%.
What the Numbers Show
A key analytical observation is the divergence between revenue trends and profitability metrics. While operational revenue fell nearly 15%, EBITDA grew by nearly 29%. This indicates substantial operating leverage, likely stemming from fixed cost absorption efficiencies or favorable input price dynamics relative to output prices. Caprolactam prices, a key raw material, stood at $1,879/MT in FY26 compared to $1,368/MT in FY25; the ability to expand margins despite higher input costs suggests effective pricing power or hedging strategies by management.
Balance Sheet and Cash Position
The company strengthened its balance sheet, with net surplus cash rising to ₹4,284 million from ₹3,256 million in FY25. Total borrowings reduced significantly to ₹199 million (₹60 million non-current and ₹139 million current) from ₹339 million in FY25. Investments increased to ₹4,887 million (₹1,403 million non-current and ₹3,484 million current), reflecting a strong liquidity position. The promoter holding remains at 24.86%, while public holding stands at 62.04%.
Historical Stock Returns for Century Enka
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.58% | +5.60% | +9.44% | +28.54% | +8.56% | +32.30% |
How sustainable is the current margin expansion given the significant year-over-year increase in caprolactam prices, and what hedging strategies is management employing to protect against further raw material volatility?
With operational revenue declining by nearly 15% due to lower sales volumes, what specific demand-side headwinds is Century Enka facing in the Nylon Filament Yarn and Reinforcement segments, and are these trends expected to persist in Q2FY26?
Given the strengthened balance sheet with net surplus cash rising to ₹4,284 million, will the company prioritize debt reduction, capital expenditure for capacity expansion, or increased shareholder returns through buybacks in the near term?


































